First Merchants Corp’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $740K | Hold |
1,914
| – | – | 0.03% | 218 |
|
|
2026
Q1 | $560K | Hold |
1,914
| – | – | 0.02% | 242 |
|
|
2025
Q4 | $671K | Hold |
1,914
| – | – | 0.02% | 230 |
|
|
2025
Q3 | $618K | Hold |
1,914
| – | – | 0.02% | 246 |
|
|
2025
Q2 | $744K | Hold |
1,914
| – | – | 0.03% | 237 |
|
|
2025
Q1 | $833K | Buy |
1,914
+332
| +21% | +$133K | 0.03% | 229 |
|
|
2024
Q4 | $584K | Sell |
1,582
-3
| -0.2% | -$1.25K | 0.02% | 274 |
|
|
2024
Q3 | $824K | Buy |
1,585
+3
| +0.2% | +$1.6K | 0.03% | 246 |
|
|
2024
Q2 | $857K | Hold |
1,582
| – | – | 0.03% | 238 |
|
|
2024
Q1 | $820K | Sell |
1,582
-20
| -1% | -$9.95K | 0.06% | 156 |
|
|
2023
Q4 | $755K | Sell |
1,602
-2
| -0.1% | -$925 | 0.06% | 158 |
|
|
2023
Q3 | $698K | Sell |
1,604
-46
| -3% | -$20.9K | 0.06% | 152 |
|
|
2023
Q2 | $733K | Sell |
1,650
-4
| -0.2% | -$1.84K | 0.06% | 154 |
|
|
2023
Q1 | $761K | Buy |
1,654
+3
| +0.2% | +$1.43K | 0.07% | 157 |
|
|
2022
Q4 | $847K | Sell |
1,651
-158
| -9% | -$80.2K | 0.08% | 156 |
|
|
2022
Q3 | $822K | Buy |
1,809
+9
| +0.5% | +$4.31K | 0.08% | 165 |
|
|
2022
Q2 | $869K | Buy |
1,800
+64
| +4% | +$31.7K | 0.09% | 167 |
|
|
2022
Q1 | $853K | Sell |
1,736
-85
| -5% | -$38.9K | 0.07% | 172 |
|
|
2021
Q4 | $844K | Sell |
1,821
-164
| -8% | -$69K | 0.07% | 178 |
|
|
2021
Q3 | $740K | Buy |
1,985
+239
| +14% | +$90.8K | 0.05% | 184 |
|
|
2021
Q2 | $667K | Hold |
1,746
| – | – | 0.04% | 184 |
|
|
2021
Q1 | $627K | Sell |
1,746
-140
| -7% | -$45K | 0.04% | 192 |
|
|
2020
Q4 | $606K | Sell |
1,886
-181
| -9% | -$55.5K | 0.04% | 192 |
|
|
2020
Q3 | $555K | Buy |
2,067
+638
| +45% | +$172K | 0.04% | 193 |
|
|
2020
Q2 | $376K | Hold |
1,429
| – | – | 0.03% | 199 |
|
|
2020
Q1 | $324K | Hold |
1,429
| – | – | 0.04% | 199 |
|
|
2019
Q4 | $432K | Sell |
1,429
-329
| -19% | -$90.5K | 0.04% | 208 |
|
|
2019
Q3 | $422K | Sell |
1,758
-110
| -6% | -$30.1K | 0.04% | 215 |
|
|
2019
Q2 | $527K | Sell |
1,868
-40
| -2% | -$10.9K | 0.08% | 158 |
|
|
2019
Q1 | $548K | Sell |
1,908
-60
| -3% | -$17.4K | 0.09% | 158 |
|
|
2018
Q4 | $517K | Buy |
1,968
+790
| +67% | +$217K | 0.1% | 154 |
|
|
2018
Q3 | $323K | Sell |
1,178
-100
| -8% | -$26K | 0.05% | 182 |
|
|
2018
Q2 | $304K | Hold |
1,278
| – | – | 0.05% | 187 |
|
|
2018
Q1 | $281K | Hold |
1,278
| – | – | 0.05% | 188 |
|
|
2017
Q4 | $288K | Buy |
+1,278
| New | +$272K | 0.05% | 192 |
|
Other funds holding ELV
DC
CF
MIHAS
ZIC
PAS
RT
First Merchants Corp's ELV Position: Q2 2026 in Review
First Merchants Corp held its Elevance Health (ELV) position steady in Q2 2026 at 1,914 shares worth $740K. The position accounts for 0.03% of the portfolio, ranked #218.
First Merchants Corp first reported a position in ELV in Q4 2017 and has held it in 35 quarters since. The position peaked at $869K in Q2 2022. 199 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- First Merchants Corp held 1,914 shares of Elevance Health worth $740K as of Q2 2026.
- First Merchants Corp left its Elevance Health share count unchanged in Q2 2026.
- Elevance Health made up 0.03% of First Merchants Corp's portfolio in Q2 2026, its #218 holding.
- First Merchants Corp first reported a position in Elevance Health in Q4 2017 and has held it in 35 quarters since.
- First Merchants Corp's Elevance Health position peaked at $869K in Q2 2022.
- 199 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on First Merchants Corp's 13F filing for Q2 2026, filed 15 Jul 2026.